IP Library Granted Patent US 8,965,490
Granted Patent B2
US 8,965,490 · App. 13/829,650 · Granted Feb 24, 2015

Systems and methods for detection of the superior vena cava area

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,965,490
App. No.
13/829,650
Granted
Feb 24, 2015
Kind
B2
Abstract

Described herein are systems, devices and methods to increase the accuracy of intravascular catheter placement, and to improve electrocardiogram (ECG), intravascular electrogram, and ultrasound Doppler signal processing to detect the Superior Vena Cava (SVC) area. Embodiments of the invention are intended to place an intravascular catheter within the lower ⅓ of SVC to the junction of the SVC and the right atrium (RA)—called the cavoatrial junction (CAJ). In particular, the improved accuracy of CAJ location detection during an intravascular catheter placement can be provided by optimization of ECG parameters and ultrasound Doppler signal using Neuro-Fuzzy logic and/or other processing techniques.

Claims (45)

1. A method for determining the location of a portion of a medical device within a body, the method comprising:

inserting at least part of the medical device into the venous vasculature of the body;

measuring an initial electrocardiogram waveform using an intravascular electrocardiogram electrode following the insertion;

advancing the medical device within the venous vasculature of the body;

measuring a second electrocardiogram waveform using the intravascular electrocardiogram electrode following the advancement of the medical device;

extracting an initial amplitude of the R wave and an initial amplitude of the S wave from the initial electrocardiogram waveform;

extracting a beat-to-beat amplitude of the R wave and a beat-to-beat amplitude of the S wave from the second electrocardiogram waveform;

determining a first difference between the initial amplitude of the R wave and the initial amplitude of the S wave;

determining a second difference between the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave;

determining a ratio of the first difference between the initial amplitude of the R wave and the initial amplitude of the S wave and the second difference between the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave;

comparing the ratio with one or more predetermined threshold feature values; and

determining whether the portion of the medical device is at the superior vena cava of the body based on the comparison of the ratio with the one or more threshold feature values.

2. The method of claim 1 , further comprising:

measuring an external electrocardiogram waveform using an external electrocardiogram electrode;

extracting an external amplitude of the R wave and an external amplitude of the S wave from the external electrocardiogram waveform; and

determining a third difference between the external amplitude of the R wave and the external amplitude of the S wave of the external electrocardiogram waveform.

3. The method of claim 2 , further comprising determining a second ratio of the second difference between the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave to the third difference between the external amplitude of the R wave and the external amplitude of the S wave.

4. The method of claim 3 , wherein determining that the portion of the medical device is in the superior vena cava is further based on a comparison of the second ratio to an amplitude ratio threshold.

5. The method of claim 4 , wherein the amplitude ratio threshold is 1.4.

6. The method of claim 3 , wherein determining that the portion of the medical device is in the superior vena cava comprises determining that the ratio is greater than or equal to half of a first threshold but less than the first threshold, and the second ratio is greater than or equal to an amplitude ratio threshold.

7. The method of claim 6 , wherein the first threshold is 1.6.

8. The method of claim 3 , wherein determining that the portion of the medical device is in the superior vena cava comprises determining that the ratio is less than half of a first threshold, and the second ratio is greater than or equal to an amplitude ratio threshold.

9. The method of claim 8 , wherein the first threshold is 1.8.

10. The method of claim 1 , wherein the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave are extracted from multiple averaged electrocardiogram waveforms.

11. The method of claim 1 , wherein the portion of the medical device is a distal portion of the medical device.

12. The method of claim 1 , wherein:

measuring the second electrocardiogram waveform using the intravascular electrocardiogram electrode comprises measuring five or more second electrocardiogram waveforms using the intravascular electrocardiogram electrode; and

extracting the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave from the second electrocardiogram waveform comprises extracting the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave from an average of the five or more second electrocardiogram waveforms.

13. A system for determining the location of a portion of a medical device within a body, the system comprising:

an elongate body having an intravascular electrocardiogram electrode disposed on a distal portion of the elongate body, the elongate body being configured to be inserted into the venous vasculature of the body;

one or more processors configured to receive and process an electrocardiogram signal from the intravascular electrocardiogram electrode; and

memory for storing instructions, which when executed by the one or more processors, causes the one or more processors to:

measure an initial electrocardiogram waveform using an intravascular electrocardiogram electrode following the insertion;

measure a second electrocardiogram waveform using the intravascular electrocardiogram electrode following advancement of the medical device;

extract an initial amplitude of the R wave and an initial amplitude of the S wave from the initial electrocardiogram waveform;

extract a beat-to-beat amplitude of the R wave and a beat-to-beat amplitude of the S wave from the second electrocardiogram waveform;

determine a first difference between the initial amplitude of the R wave and the initial amplitude of the S wave;

determine a second difference between the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave;

determine a ratio of the first difference between the initial amplitude of the R wave and the initial amplitude of the S wave and the second difference between the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave;

compare the ratio with one or more predetermined threshold feature values; and

determine whether the portion of the medical device is at the superior vena cava of the body based on the comparison of the ratio with the one or more threshold feature values.

14. The system of claim 13 , wherein the portion of the medical device is the distal portion of the medical device.

15. The system of claim 13 , wherein the one or more processors are configured to:

measure the second electrocardiogram waveform using the intravascular electrocardiogram electrode by measuring five or more second electrocardiogram waveforms using the intravascular electrocardiogram electrode; and

extract the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave from the second electrocardiogram waveform by extracting the beat-to-beat amplitude of the R wave and the beat-to-beat amplitude of the S wave from an average of the five or more second electrocardiogram waveforms.

Assignments (7)
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066621/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066617/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2022
From: ARROW INTERNATIONAL LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058917/0270 →
CONVERSION AND CHANGE OF NAME Recorded Sep 10, 2020
From: ARROW INTERNATIONAL, INC.
To: ARROW INTERNATIONAL LLC
Reel/Frame 053754/0731 →
SECURITY INTEREST Recorded Oct 3, 2019
From: ARROW INTERNATIONAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 050619/0681 →
MERGER Recorded Feb 19, 2018
From: VASONOVA, INC.
To: ARROW INTERNATIONAL, INC.
Reel/Frame 044967/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2015
From: LEE, KICHANG; WENZEL, BRIAN J.; JIANG, JIN; HANLON, STEPHEN P.
To: VASONOVA, INC.
Reel/Frame 034648/0404 →